Cancidas Lyophilisate For Solution For Injection 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Cancidas: Lyophilisate for solution for injection (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CASPOFUNGIN (kas poe FUN jin) is an antifungal medicine. It is used to treat certain kinds of fungal or yeast infections.

In-Depth Information

Cancidas 50mg Powder for Injection

NDC: 000063822
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pneumonia, Peritonitis, Febrile Neutropenia, Aspergillosis, Esophageal Candidiasis, Intraabdominal Infections, Bone And Joint Infections, Intraabdominal Abscess, Candidiasis, Infectious Arthritis, Candidemia, Osteomyelitis

Sometimes used for but not FDA approved for the following conditions:
Candidiasis Prophylaxis, Aspergillosis Prophylaxis, Endocarditis, Oropharyngeal Candidiasis (thrush)

Storage Information
Store unreconstituted product in refrigerator (36 to 46 degrees F)
Reconstituted product prepared as infusion may be stored below 77 degrees F for up to 24 hours or 36 to 46 degrees F for 48 hours.
Discard product if it contains particulate matter, is cloudy, or discolored
Discard unused portion. Do not store for later use.
Cancidas 50mg Powder for Injection

Reported Side Effects for Cancidas 50mg Powder for Injection

Low White Blood Cells Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Red Spotted Rash Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Injection Site Reaction Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Hypoxia Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Coagulopathy Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Blood In The Urine Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
<14.0%*
Severity: MILD
Onset: DELAYED
Yellow Skin Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Enlarged Liver Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Abnormal Heart Rhythm Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Liver Failure Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Flushing Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Confusion Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Irregular Heart Beat Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Slow Heart Beat Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Suddenly Stopped Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Constipation Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<9.0%*
Severity: MODERATE
Onset: EARLY
Nose Bleed Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Kidney Failure Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
High Calcium Levels Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Irritated Blood Vessels Incidence:
<18.0%*
Severity: MODERATE
Onset: RAPID
Low Magnesium Levels Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Rapid Breathing Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Anemia Incidence:
2.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
3.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Skin Ulcer Incidence:
3.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
3.0-20.0%*
Severity: MODERATE
Onset: RAPID
Rapid Heart Rate Incidence:
4.0-11.0%*
Severity: MODERATE
Onset: RAPID
Skin Rash Incidence:
4.0-23.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
4.0-9.0%*
Severity: MODERATE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
4.0-13.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
4.0-9.0%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
5.0-8.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
5.0-10.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
5.0-15.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
6.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
6.0-7.0%*
Severity: MILD
Onset: RAPID
Cough Incidence:
6.0-11.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
6.0-13.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
6.0-30.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
6.0-27.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Fluid Around The Lungs Incidence:
9.0%*
Severity: SEVERE
Onset: DELAYED
Chills Incidence:
9.0-23.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cancidas

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5